AG348C 029 — ASO

By Hello Thread on AppTrack Ninja.

Participant Study App

This app is intended for use by participants in the AG348 C 029 study and requires an invitation and activation code from the study site to register. AG348-C-029, A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Subjects With α- or βTransfusion-Dependent Thalassemia (ENERGIZEKids-T). This study has been reviewed and approved by the appropriate regulatory body, e.g. Institutional Review Board (IRB) or Independent Ethics Committee (IEC). Key App Features: - Patient Onboarding – complete stu…

Categories: Medical, Health & Fitness

Keyword visibility, ranked search terms and daily position movement for AG348C 029.